Molecular Characterization of Ambiguous Mutations in HIV-1 Polymerase Gene: Implications for Monitoring HIV Infection Status and Drug Resistance

Division of Global HIV/AIDS, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States of America.
PLoS ONE (Impact Factor: 3.23). 10/2013; 8(10):e77649. DOI: 10.1371/journal.pone.0077649
Source: PubMed


Detection of recent HIV infections is a prerequisite for reliable estimations of transmitted HIV drug resistance (t-HIVDR) and incidence. However, accurately identifying recent HIV infection is challenging due partially to the limitations of current serological tests. Ambiguous nucleotides are newly emerged mutations in quasispecies, and accumulate by time of viral infection. We utilized ambiguous mutations to establish a measurement for detecting recent HIV infection and monitoring early HIVDR development. Ambiguous nucleotides were extracted from HIV-1 pol-gene sequences in the datasets of recent (HIVDR threshold surveys [HIVDR-TS] in 7 countries; n=416) and established infections (1 HIVDR monitoring survey at baseline; n=271). An ambiguous mutation index of 2.04×10(-3) nts/site was detected in HIV-1 recent infections which is equivalent to the HIV-1 substitution rate (2×10(-3) nts/site/year) reported before. However, significantly higher index (14.41×10(-3) nts/site) was revealed with established infections. Using this substitution rate, 75.2% subjects in HIVDR-TS with the exception of the Vietnam dataset and 3.3% those in HIVDR-baseline were classified as recent infection within one year. We also calculated mutation scores at amino acid level at HIVDR sites based on ambiguous or fitted mutations. The overall mutation scores caused by ambiguous mutations increased (0.54×10(-2)3.48×10(-2)/DR-site) whereas those caused by fitted mutations remained stable (7.50-7.89×10(-2)/DR-site) in both recent and established infections, indicating that t-HIVDR exists in drug-naïve populations regardless of infection status in which new HIVDR continues to emerge. Our findings suggest that characterization of ambiguous mutations in HIV may serve as an additional tool to differentiate recent from established infections and to monitor HIVDR emergence.

Download full-text


Available from: Karidia Diallo, Mar 07, 2014
1 Follower
32 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In Serbia, the first cases of HIV infection were reported in 1985, whereas antiretroviral therapy has been in use since 1987. With this study we aimed to assess the occurrence and pattern of HIV resistance mutations among newly diagnosed patients, in the period 2002-2011. The study prospectively included 181 adult patients. Genotypic HIV-1 drug resistance testing was performed and drug resistance was scored according to the 2009 WHO list for surveillance of drug-resistance mutations (SDRMs). Bioinformatic approach was used for estimation of duration of infection by calculating percentage of ambiguous basecalls per sequence, with the cut-off of 0.47% as delimitator for recent infection. The overall prevalence of TDR found in the study was 8.8% (16/181, 95% CI = 5.5-13.8). Thirty one percent of resistant samples contained multiple SDRMs. In particular, 5/16 patients with resistance carried viral strains with SDRMs to multiple ARV classes, hence one third of resistant strains were multiclass resistant, including also non-B strains. A total of 51.9% of samples (94/181) were classified as recent infection, with the significant increase in the second part of the study period. However, TDR prevalence in recent infection was 6.4% (6/94, 95% CI = 2.9-13.2), not statistically different to the one in non-recent infection. We showed a changing pattern of TDR mutations over the study period, with substantial occurrence of multiclass resistance, across different HIV subtypes. Our results highlight the need for continued surveillance of primary resistance.
    AIDS research and human retroviruses 03/2014; 30(7). DOI:10.1089/AID.2013.0270 · 2.33 Impact Factor